Dario Amodei’s Anthropic says its Claude AI model “autonomously discovered” a new enzyme system resembling the molecular machinery behind CRISPR gene editing, the first result to come out of the company’s newly launched wet lab.

Anthropic is framing the discovery as an early test of whether Claude can actually be useful to scientists, and the timing is notable: it comes as the company prepares to go public in a potential trillion-dollar IPO. Human involvement, Anthropic says, was limited to writing an initial prompt and running the physical lab work. The AI did the searching and analysis itself.

The process started with a search through a…

Read the full article at BREITBART.COM